Durlobactam

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Durlobactam is a beta-lactamase inhibitor used in combination with sulbactam to treat susceptible strains of bacteria in the genus Acinetobacter It is an analog of avibactam. The combination therapy sulbactam/durlobactam was approved for medical use in the United States in May 2023.

Durlobactam is a beta-lactamase inhibitor used in combination with sulbactam to treat susceptible strains of bacteria in the genus Acinetobacter It is an analog of avibactam. The combination therapy sulbactam/durlobactam was approved for medical use in the United States in May 2023.

See also

Diazabicyclooctane β-lactamase inhibitor ETX0462

Text derived from https://en.wikipedia.org/w/index.php?oldid=1363446725 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

1 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.